BioSpace News Archive

Global Blood Therapeutics, Inc. announced that on July 1, 2022, the compensation committee of GBT’s board of directors granted 22 new employees options to purchase an aggregate of 10,600 shares of the company’s common stock with a per share exercise price of $32.80 and restricted stock units for an aggregate 76,600 shares of the company’s common stock.

An excellent Oncolytic Virus Immunotherapy market survey report is generated with the combination of best industry insight, practical solutions, talent solutions, and latest technology.

Haemonetics Corporation announced that the Company intends to publish first quarter fiscal year 2023 financial results at 6:00 am EDT on Wednesday, August 10, 2022.

SPEXIS AG, a clinical-stage biopharmaceutical company, announced that its CXCR4 inhibitor balixafortide demonstrated synergistic efficacy in combination with docetaxel compared to either drug alone in a metastatic prostate cancer preclinical model.

Genespire, a next generation gene therapy company developing first-in-class transformative therapies with advanced lentiviral vectors, today announces the appointment of Dr. Sabah Sallah MD, PhD as Chief Medical Officer.

The oversubscribed first close of Series B funding was led by Cathay Health, joined by Credit Mutuel Innovation, Kurma Partners and BNP Paribas Développement.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Advancements in the field of nanotechnology and soaring need for metal nanoparticles across various end-use industries are likely to significantly rub off on demand for gold nanoparticles.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global dental services market was valued at US$ 326.3 Bn in 2021.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The effervescent products market may record massive growth across the assessment period of 2021-2031.

The global clinical trials matching software market is anticipated to expand at a favorable rate from 2021 to 2031.